Cargando…
Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis
Lupus nephritis (LN) is one of the most severe complications in patients with systemic lupus erythematosus (SLE). Traditionally, LN is regarded as an immune complex (IC) deposition disease led by dsDNA–anti-dsDNA-complement interactions in the subendothelial and/or subepithelial basement membrane of...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298725/ https://www.ncbi.nlm.nih.gov/pubmed/37373215 http://dx.doi.org/10.3390/ijms241210066 |
_version_ | 1785064189190995968 |
---|---|
author | Tsai, Chang-Youh Li, Ko-Jen Shen, Chieh-Yu Lu, Cheng-Hsun Lee, Hui-Ting Wu, Tsai-Hung Ng, Yee-Yung Tsao, Yen-Po Hsieh, Song-Chou Yu, Chia-Li |
author_facet | Tsai, Chang-Youh Li, Ko-Jen Shen, Chieh-Yu Lu, Cheng-Hsun Lee, Hui-Ting Wu, Tsai-Hung Ng, Yee-Yung Tsao, Yen-Po Hsieh, Song-Chou Yu, Chia-Li |
author_sort | Tsai, Chang-Youh |
collection | PubMed |
description | Lupus nephritis (LN) is one of the most severe complications in patients with systemic lupus erythematosus (SLE). Traditionally, LN is regarded as an immune complex (IC) deposition disease led by dsDNA–anti-dsDNA-complement interactions in the subendothelial and/or subepithelial basement membrane of glomeruli to cause inflammation. The activated complements in the IC act as chemoattractants to chemically attract both innate and adaptive immune cells to the kidney tissues, causing inflammatory reactions. However, recent investigations have unveiled that not only the infiltrating immune-related cells, but resident kidney cells, including glomerular mesangial cells, podocytes, macrophage-like cells, tubular epithelial cells and endothelial cells, may also actively participate in the inflammatory and immunological reactions in the kidney. Furthermore, the adaptive immune cells that are infiltrated are genetically restricted to autoimmune predilection. The autoantibodies commonly found in SLE, including anti-dsDNA, are cross-reacting with not only a broad spectrum of chromatin substances, but also extracellular matrix components, including α-actinin, annexin II, laminin, collagen III and IV, and heparan sulfate proteoglycan. Besides, the glycosylation on the Fab portion of IgG anti-dsDNA antibodies can also affect the pathogenic properties of the autoantibodies in that α-2,6-sialylation alleviates, whereas fucosylation aggravates their nephritogenic activity. Some of the coexisting autoantibodies, including anti-cardiolipin, anti-C1q, anti-ribosomal P autoantibodies, may also enhance the pathogenic role of anti-dsDNA antibodies. In clinical practice, the identification of useful biomarkers for diagnosing, monitoring, and following up on LN is quite important for its treatments. The development of a more specific therapeutic strategy to target the pathogenic factors of LN is also critical. We will discuss these issues in detail in the present article. |
format | Online Article Text |
id | pubmed-10298725 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102987252023-06-28 Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis Tsai, Chang-Youh Li, Ko-Jen Shen, Chieh-Yu Lu, Cheng-Hsun Lee, Hui-Ting Wu, Tsai-Hung Ng, Yee-Yung Tsao, Yen-Po Hsieh, Song-Chou Yu, Chia-Li Int J Mol Sci Review Lupus nephritis (LN) is one of the most severe complications in patients with systemic lupus erythematosus (SLE). Traditionally, LN is regarded as an immune complex (IC) deposition disease led by dsDNA–anti-dsDNA-complement interactions in the subendothelial and/or subepithelial basement membrane of glomeruli to cause inflammation. The activated complements in the IC act as chemoattractants to chemically attract both innate and adaptive immune cells to the kidney tissues, causing inflammatory reactions. However, recent investigations have unveiled that not only the infiltrating immune-related cells, but resident kidney cells, including glomerular mesangial cells, podocytes, macrophage-like cells, tubular epithelial cells and endothelial cells, may also actively participate in the inflammatory and immunological reactions in the kidney. Furthermore, the adaptive immune cells that are infiltrated are genetically restricted to autoimmune predilection. The autoantibodies commonly found in SLE, including anti-dsDNA, are cross-reacting with not only a broad spectrum of chromatin substances, but also extracellular matrix components, including α-actinin, annexin II, laminin, collagen III and IV, and heparan sulfate proteoglycan. Besides, the glycosylation on the Fab portion of IgG anti-dsDNA antibodies can also affect the pathogenic properties of the autoantibodies in that α-2,6-sialylation alleviates, whereas fucosylation aggravates their nephritogenic activity. Some of the coexisting autoantibodies, including anti-cardiolipin, anti-C1q, anti-ribosomal P autoantibodies, may also enhance the pathogenic role of anti-dsDNA antibodies. In clinical practice, the identification of useful biomarkers for diagnosing, monitoring, and following up on LN is quite important for its treatments. The development of a more specific therapeutic strategy to target the pathogenic factors of LN is also critical. We will discuss these issues in detail in the present article. MDPI 2023-06-13 /pmc/articles/PMC10298725/ /pubmed/37373215 http://dx.doi.org/10.3390/ijms241210066 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Tsai, Chang-Youh Li, Ko-Jen Shen, Chieh-Yu Lu, Cheng-Hsun Lee, Hui-Ting Wu, Tsai-Hung Ng, Yee-Yung Tsao, Yen-Po Hsieh, Song-Chou Yu, Chia-Li Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis |
title | Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis |
title_full | Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis |
title_fullStr | Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis |
title_full_unstemmed | Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis |
title_short | Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis |
title_sort | decipher the immunopathological mechanisms and set up potential therapeutic strategies for patients with lupus nephritis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298725/ https://www.ncbi.nlm.nih.gov/pubmed/37373215 http://dx.doi.org/10.3390/ijms241210066 |
work_keys_str_mv | AT tsaichangyouh deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis AT likojen deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis AT shenchiehyu deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis AT luchenghsun deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis AT leehuiting deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis AT wutsaihung deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis AT ngyeeyung deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis AT tsaoyenpo deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis AT hsiehsongchou deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis AT yuchiali deciphertheimmunopathologicalmechanismsandsetuppotentialtherapeuticstrategiesforpatientswithlupusnephritis |